Patents: Lifeblood of Biotech or a Cancer to Innovation?
By Anette Breindl
Monday, May 25, 2009
Patent challenges - long a favorite parlor game in the biotech industry, at least for plaintiffs - received a new twist recently with a lawsuit brought by the American Civil Liberties Union and a number of co-plaintiffs against Utah biotechnology company Myriad Genetics and the University of Utah Research Foundation.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.